Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions

Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions

Thumbnail Image
Download
Name

Saha-2011-Surface-engineered s.pdf

Size

1.32 MB

Format

Adobe PDF

Checksum (MD5)

8be60e4b15192f0f105f21dae3745a1e

Author(s)
Saha, Krishanu
•
Mei, Ying
•
Reisterer, Colin M.
•
Pyzocha, Neena Kenton
•
Yang, Jing
•
Muffat, Julien
•
Davies, Martyn C.
•
Alexander, Morgan R.
•
Jaenisch, Rudolf
•
Langer, Robert S
more
Date Issued
November 2011
Journal
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Citation
Saha, K. et al. “Surface-engineered Substrates for Improved Human Pluripotent Stem Cell Culture Under Fully Defined Conditions.” Proceedings of the National Academy of Sciences 108.46 (2011): 18714–18719. Copyright ©2011 by the National Academy of Sciences
Version
Final published version
Abstract
The current gold standard for the culture of human pluripotent stem cells requires the use of a feeder layer of cells. Here, we develop a spatially defined culture system based on UV/ozone radiation modification of typical cell culture plastics to define a favorable surface environment for human pluripotent stem cell culture. Chemical and geometrical optimization of the surfaces enables control of early cell aggregation from fully dissociated cells, as predicted from a numerical model of cell migration, and results in significant increases in cell growth of undifferentiated cells. These chemically defined xeno-free substrates generate more than three times the number of cells than feeder-containing substrates per surface area. Further, reprogramming and typical gene-targeting protocols can be readily performed on these engineered surfaces. These substrates provide an attractive cell culture platform for the production of clinically relevant factor-free reprogrammed cells from patient tissue samples and facilitate the definition of standardized scale-up friendly methods for disease modeling and cell therapeutic applications.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Biology
Massachusetts Institute of Technology. Department of Chemical Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/74094
DOI of Published Version
https://doi.org/10.1073/pnas.1114854108
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.